|
United pharmacists brand
oral laxative mineral oil added to list of recalled
products
May 26 2006
As a precautionary measure, Health
Canada is advising
consumers not to use United Pharmacists brand
oral laxative mineral oil packaged in round white
plastic bottles. Recent information suggests that
the oil may cause the bottle to degrade over time
and produce a potential cancer-causing agent.
Health Canada previously
advised consumers on April 28, 2006 not to
use several other brands of oral laxative mineral
oil due to this potential health risk. All the
mineral oil products that may cause the round
white plastic bottles to degrade over time are
manufactured by R.W. Packaging of Winnipeg and
are sold under the brand names Pure Standard Products
(PSP), Regal, Encounter, Medicine Centre, People’s,
People’s First, Pharmachoice, Pharmasave,
Rexall, and Value Brand. The plastic bottles have
“HDPE” stamped on the bottom. The
Drug Identification Numbers (DINs) for these mineral
oil products are 00167681 (regular) and 01935348
(heavy) and can be found on the product label.
R.W. Packaging is recalling these
products, as well as the United Pharmacists mineral
oil products with the same DINs as above, as a
precautionary measure.
The potential risk of developing
a cancer-causing agent is not present when the
mineral oil is packaged in glass bottles or in
colourless rectangular plastic bottles.
Although occasional use of these
products poses a very minimal health risk, consumers
who may have purchased these products are advised
not to use them and should consult with a health
care professional if they have concerns about
their health due to the use of these products.
Consumers should not discard these products until
they have received guidance from their Municipal
Government regarding their safe disposal.
Consumers requiring more information
about this advisory can contact Health Canada’s
public enquiries line at (613) 957-2991, or toll
free at 1-866-225-0709.
To report a suspected adverse reaction
with these or any other health product, please
contact the Canadian Adverse Drug Reaction Monitoring
Program (CADRMP) of Health Canada by one of the
following methods:
Telephone: 866-234-2345
Facsimile: 866-678-6789
CADRMP
Marketed Health Products Directorate
Health Protection Building, Tunney's Pasture,
AL 0701C
Ottawa, ON
K1A 0K9
Email: cadrmp@hc-sc.gc.ca
|
